[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ahluwalia et al., 1970 - Google Patents

Effects of exogenous hormones on the male reproductive organs of vitamin A-deficient rats

Ahluwalia et al., 1970

Document ID
16735073889735482981
Author
Ahluwalia B
Bieri J
Publication year
Publication venue
The Journal of Nutrition

External Links

Snippet

The purpose of this study was to determine if the degenerative changes seen in testes in vitamin A deficiency could be prevented by administering hormones. Rats deficient in retinol but supplemented with retinoic acid were injected daily with various doses of testosterone …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Saginor et al. Reflex release of gonadotropin and increased plasma testosterone concentration in male rabbits during copulation
McDonald et al. Comparison of the effect of neonatal administration of testosterone and dihydrotestosterone in the female rat
Brown-Grant et al. The effects of the administration of testosterone propionate alone or with phenobarbitone and of testosterone metabolites to neonatal female rats
MONEY et al. Effects of adrenal and gonadal products on the weight and radioiodine uptake of the thyroid gland in the rat
Emanuele et al. The endocrine system: alcohol alters critical hormonal balance
FAROOKHI Effects of androgen on induction of gonadotropin receptors and gonadotropin-stimulated adenosine 3′, 5′-monophosphate production in rat ovarian granulosa cells
Sylvester et al. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the “critical period” after carcinogen administration
Ahluwalia et al. Effects of exogenous hormones on the male reproductive organs of vitamin A-deficient rats
Collu et al. Endocrine effects of chronic administration of psychoactive drugs to prepuberal male rats. I: Δ9-tetrahydrocannabinol
Lamberts et al. Studies on the mechanism of the GABA-mediated inhibition of prolactin secretion
Goldberg et al. Studies on the nature of the thyroidpituitary interrelationship
Mahamed et al. Effects of metformin on the reproductive system of androgenized female rats
HENDERSON et al. Methylandrostenediol
Rattner et al. Plasma gonadotropins, prolactin and progesterone at the time of implantation in the mouse: effects of hypoxia and restricted dietary intake
Adams et al. Progesterone inhibits the uterotrophic effect of relaxin in immature rats
Goomer et al. Effect of neonatal testosterone and oestradiol treatment on the development of the hypothalamo-hypophysial axis in the female rat
Louchart et al. Inactivation of ll-Dehydro-17-Hydroxycorticosterone by Tissue Slices.
Tisell Effect of cortisone on the growth of the ventral prostate, the dorsolateral prostate, the coagulating glands and the seminal vesicles in castrated adrenalectomized and castrated non-adrenalectomized rats
Bengmark et al. Endocrine dependence of rat prostatic tissue in vitro
US4163011A (en) Peptide compounds and compositions
Constantinides et al. The effect of glucose on the adrenal response to ACTH in hypophysectomized rats
Grady et al. Studies on interactions between the ovary and pituitary follicle-stimulating hormone in the golden hamster
Atkinson et al. LH, FSH and ovulation rate in ewes treated with exogenous oestradiol
Jean-Faucher et al. Sexual maturation in male mice treated with cyproterone acetate from birth to puberty
Heimberg et al. Effect of adrenocortical and hypophyseal hormones on uptake of fat by isolated perfused liver